Katie Porter attacks pharma
World of DTC Marketing
JANUARY 31, 2021
I always have pointed instances in which pharma puts Wall Street first and patients second. Porter points out that R&D seems to have been replaced with mergers and acquisitions, but she misses the big picture by focusing solely on drug costs. In pharma R&D returns have declined to 1.8 percent—a slight decrease of 0.1
187 
Let's personalize your content